Home » Topics » Science » New compound

New compound
RSS

[68Ga]Desferal developed for imaging of bacterial infections

Nov. 5, 2020

Discovery of novel DNA-PK inhibitors as radiosensitizers

Nov. 5, 2020

Biodistribution, dosimetry and preclinical efficacy data presented for [177Lu]rhPSMA-7.3

Nov. 4, 2020

Preclinical data presented for the PSMA analogue [47Sc]Sc-PSMA-D4

Nov. 3, 2020

dEF-3122 improves inflammation and fibrosis in liver and kidneys of NASH mice

Nov. 3, 2020

NMBS-2: a selective and potent HPK1 inhibitor for enhancing antitumor immunity

Oct. 29, 2020

Novel selective TRK degraders effectively reduce TPM3-TRKA fusion protein levels

Oct. 28, 2020

APJ-specific PET radiotracer predictive of post-ischemic angiogenesis

Oct. 27, 2020

Furin inhibitor BOS-318 seems effective for treating cystic fibrosis

Oct. 19, 2020

Bromodomain 2-selective BET inhibitors show antitumor effect in pediatric cancer models

Oct. 19, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...